L3Harris Technologies Inc vs Nuwellis Inc — how do they compare? L3Harris Technologies Inc trades at $285.09 (market cap $53.26B), while Nuwellis Inc trades at $1.41 (market cap $542.80K). The key difference: L3Harris Technologies Inc is far larger — about 98120.9× Nuwellis Inc's market cap, and L3Harris Technologies Inc pays a 1.75% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| LHX | NUWE | |
|---|---|---|
Market Cap | $53.26B | $542.80K |
Sector | Industrials | Technology |
52-Week High | $378.48 | $220.50 |
52-Week Low | $270.21 | $1.42 |
Enterprise Value | $63.71B | -$1.27M |
Dividend Yield | 1.75% | — |
Signals from Pluang's Aura AI — not financial advice
LHX trades at $285.18, down 1.57% today, with strong fundamental performance including three consecutive quarterly EPS beats and record $42 billion backlog. The company shows improving profitability with net margin expanding to 8.11% in 2026 projections. Recent defense contract wins and successful missile tests highlight operational momentum, though technical indicators show bearish pressure with price below key resistance levels.
LHX presents a compelling investment case with strong defense sector positioning, consistent earnings outperformance, and 72.7% analyst buy ratings targeting $319.33. Key risks include defense budget volatility and execution challenges in scaling production. The stock offers 12% upside to consensus target with dividend yield support, though near-term technical weakness requires monitoring.
NUWE trades at $1.43, up 0.7% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported a net loss of -$17.52M in 2025, with a negative net income margin of -217.22%, though recent news highlights product development and revenue growth initiatives, including a 14% preliminary year-over-year revenue increase in Q2 2026.
Outlook is cautious due to persistent losses and high cash burn, but growth in pediatric installations and strategic expansions offer potential. Risks include financial sustainability and competitive pressures, while analyst coverage is limited with a split buy/hold consensus.
Trailing returns across standard periods
Latest headlines on both assets
L3Harris Technologies was created in 2019 from the merger of L3 Technologies and Harris, two defense contractors that provide products for the command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR) market. The firm also has smaller operations serving the civil government, particularly the Federal Aviation Administration's communication infrastructure, and produces various avionics for defense and commercial aviation.
Read more on LHX →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →